BioSpace News Archive

Clinical Computer Systems, Inc. (CCSI), has entered into a cooperation agreement with Huntleigh Healthcare Limited, to sell the new OBIX BeCA Fetal Monitor, pending FDA 510K clearance, in the United States.

Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center held a ribbon cutting event yesterday to commemorate the opening of the facility.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the U.S. Food and Drug Administration (FDA) approved the company’s supplemental New Drug Application (sNDA) for Emflaza® (deflazacort) to expand its labeling to include patients with Duchenne muscular dystrophy who are between 2- and 5-years-old

Experts from the ProfNet network who are available to discuss timely issues in your coverage area.

MedPro Healthcare Staffing has awarded scholarships to three specially selected students from Marjory Stoneman Douglas High School as part of the Helena Ramsay Soaring Leader Scholarship.

Pharma Logistics broke ground today on its new facility on North Butterfield Road in Libertyville, Illinois. The groundbreaking ceremony was attended by Pharma Logistics leadership and staff, village officials and valued guests.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action has been filed on behalf of investors who purchased or otherwise acquired the securities of Indivior plc between March 10, 2015 and April 9, 2019, inclusive.

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) will release its financial results for the fourth quarter and fiscal year ended March 31, 2019 after financial markets close on June 20, 2019.

Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) are today presenting research that shows higher levels of advanced glycation end products (AGEs), found in abundance in junk food, are associated with food allergy in children.

Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announced today that positive study results have been published in the Journal of Clinical Investigation (JCI) Insight1.